SciELO - Scientific Electronic Library Online

 
vol.32 número3Cellular origin and regulation of kidney fibrosisLight chain deposition disease: atypical associations in a rare disease índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Portuguese Journal of Nephrology & Hypertension

versión impresa ISSN 0872-0169

Resumen

COSTA, Marta Sofia et al. Immunoglobulin G4-related disease mimicking multiple myeloma. Port J Nephrol Hypert [online]. 2018, vol.32, n.3, pp.283-288. ISSN 0872-0169.

Immunoglobulin G4-related disease (IgG4-RD) is a rare, poorly understood immune mediated disorder. It is characterized by a wide clinical spectrum depending on the organs affected. Serum IgG4 may be elevated, but this is not mandatory. Imaging abnormalities are usually detected in the affected organs, which typically show enlarged dimensions. Definitive diagnosis is made upon tissue biopsy demonstrating lymphoplasmacytic infiltration with predominance of polyclonal IgG4-positive plasma cells, storiform fibrosis and obliterative phlebitis. The most common renal manifestations [(IgG4-related kidney disease (IgG4#8209;RKD)] include tubulointerstitial nephritis, membranous glomerulonephritis and pyelitis. There is, usually, good therapeutic response to corticosteroids, but rituximab may be needed in cases of relapsing or resistant disease. A diagnostic challenge, and because it diagnosis needs specific immunohistochemical staining techniques, IgG4-RKD should be contemplated in the differential diagnosis of obscure kidney disease in order not to be missed.

Palabras clave : Immunoglobulin G4; immunoglobulin G4-related disease; immunoglobulin G4-related kidney disease; lymphoplasmacytic infiltration; storiform fibrosis; tubulointerstitial nephritis.

        · texto en Inglés     · Inglés ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons